Institut Curie Paris

Running trials

• Not yet recruiting

  Omission of Surgery for Triple-negative Breast Cancer in Complete Response After Neoadjuvant Chemo-immunotherapy

  NCT07357948· Source

• Recruiting

  SURVEILLE-HPV: Evaluation of HPV16 Circulating DNA as Biomarker to Detect the Recurrence, in Order to Improve Post Therapeutic Surveillance of HPV16-driven Oropharyngeal Cancers

  NCT05582122· Phase 2· Source

• Recruiting

  A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  NCT06119581· Phase 3· Source

• Recruiting

  Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer Patients

  NCT05850130· Source

• Active, not recruiting

  Sacituzumab Govitecan in Primary HER2-negative Breast Cancer

  NCT04595565· Phase 3· Source

• Active, not recruiting

  Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma

  NCT02243605· Phase 2· Source

• Active, not recruiting

  Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal Melanoma

  NCT01979523· Phase 2· Source

• Active, not recruiting

  Vismodegib in Treating Patients With Advanced Chondrosarcomas

  NCT01267955· Phase 2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer1 recruiting
• Gastric and esophageal cancer1 recruiting
• Head and neck cancer1 recruiting
• Liver and biliary tract cancer1 recruiting
• Lung cancer1 recruiting
• Pancreatic cancer1 recruiting
• Triple-negative breast cancer1 recruiting

Researchers

No researcher is linked here yet.